Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clémence Mooser

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature Communications|July 16, 2022
The CIP2A-TOPBP1 complex safeguards chromosomal stability during mitosisMara De Marco Zompit, Mònica Torres Esteban, Clémence Mooser, et al.
Nature Communications|January 9, 2020
Treacle controls the nucleolar response to rDNA breaks via TOPBP1 recruitment and ATR activationClémence Mooser, Ioanna-Eleni Symeonidou, Pia-Amata Leimbacher, et al.
The Journal of Clinical Investigation|August 19, 2025
Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancerJudit Börcsök, Diyavarshini Gopaul, Daphne Devesa-Serrano, et al.
Breast (Edinburgh, Scotland)|November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancerAmandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature Communications|July 16, 2022
The CIP2A-TOPBP1 complex safeguards chromosomal stability during mitosisMara De Marco Zompit, Mònica Torres Esteban, Clémence Mooser, et al.
Nature Communications|January 9, 2020
Treacle controls the nucleolar response to rDNA breaks via TOPBP1 recruitment and ATR activationClémence Mooser, Ioanna-Eleni Symeonidou, Pia-Amata Leimbacher, et al.
The Journal of Clinical Investigation|August 19, 2025
Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancerJudit Börcsök, Diyavarshini Gopaul, Daphne Devesa-Serrano, et al.
Breast (Edinburgh, Scotland)|November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancerAmandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
Pageof 1